AdvanCell - Crunchbase Company Profile & Funding

Q: Where is AdvanCell's headquarters?

AdvanCell is located in Sydney, New South Wales, Australia.

Q: Who invested in AdvanCell?

AdvanCell has 10 investors including Medical Research Future Fund (MRFF) And Catalio Capital Management.

Q: When was the last funding round for AdvanCell?

AdvanCell closed its last funding round on obfuscated from a Grant round.

Q: How much funding has AdvanCell raised to date?

AdvanCell has raised obfuscated.

Overview

AdvanCell

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About AdvanCell

CB Rank

3700

AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.

Founded

obfuscation

Private

Grant

Sydney, New South Wales, Australia

51-100

advancell.com.au

Biotechnology

Clinical Trials

Oncology

Pharmaceutical

Funding Rounds

Grant

OBF

obfuscation

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Andrew Adamovich: CEO

Details

Legal Name

AdvanCell Isotopes Pty Ltd.

Operating Status

Active

Company Type

For Profit

Founders

Andrew Adamovich

About the Company

AdvanCell is a clinical-stage radiopharmaceutical company that develops novel cancer therapeutics. It develops alpha-emitting isotopes attached to molecules that deliver cytotoxic radiation directly to tumors at the molecular level to allow healthcare providers to provide safe and effective treatment for multiple forms of cancer.

Predictions & Insights

Growth Insight

See this Growth Insight

AdvanCell is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Alpha 212

A quality-controlled dose of lead-212 (²¹²Pb) provided as an active pharmaceutical ingredient for targeted alpha therapy development.

Targeted Alpha Therapies Portfolio

A range of targeted alpha therapies under development for treating multiple cancer types using alpha-emitting isotopes.

Research & Development

AdvanCell is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant
obfuscated obfuscation	Grant - AdvanCell	1	obfuscated obfuscation	Medical Research Future Fund (MRFF)	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Medical Research Future Fund (MRFF)	Yes	Grant - AdvanCell	—
Medical Research Future Fund (MRFF)	Yes	Grant - AdvanCell	—
Medical Research Future Fund (MRFF)	Yes	Grant - AdvanCell	—
Medical Research Future Fund (MRFF)	Yes	Grant - AdvanCell	—
Medical Research Future Fund (MRFF)	Yes	Grant - AdvanCell	—